News, Publications & Resources | PrognomiQ

NEWS & RESOURCES

Press Releases

01/09/2023

PrognomiQ’s Multi-omics Liquid Biopsy Platform Demonstrates Promising Results in Early-Stage Cancer Detection of Non-Small Cell Lung Cancer

Read More

11/29/2022

PrognomiQ Strengthens its Scientific and Clinical Leadership with the Appointment of Brian Koh, M.D. as Chief Medical Officer

Read More

06/21/2022

Maccabi’s KSM Research and Innovation Center & PrognomiQ Announce Research Collaboration Aimed at Early Cancer Detection

Read More

03/15/2022

PrognomiQ Announces $46 Million Financing to Advance Development of its Multi-omics Product Pipeline for Early Detection and Treatment of Cancer

Read More

In the News

The news articles below were developed independently and any commentary or opinions are those of the publication.

06/21/2022

PrognomiQ partners with KSM to discover cancer biomarkers

Read More

03/25/2022

PrognomiQ Exploring Multiomic Markers for Variety of Cancer Dx Applications

Read More

03/15/2022

PrognomiQ lands $46M from Bruker for multiomics platform

Read More

September 2022

High-Dimensional, Multi-Omics Analyses of Proteins, Metabolites, Transcripts, and Genes Enable Biomarker Discovery in Early- and…

See Poster

June 2022

Combining Proteograph technology with Zeno SWATH acquisition enables the potential for deep, unbiased discovery of…

See Poster

June 2022

An unbiased multi-omics approach for the detection of pancreatic cancer biomarkers utilizing ion-mobility mass spectrometry…

See Poster

April 2022

Deep, unbiased multi-omics approach for identification of pancreatic cancer biomarkers from blood

See Poster

March 2022

Incorporation of glycoproteome detection into large scale unbiased proteomics studies utilizing nanoparticles

See Poster

November 2021

Large scale, deep, and unbiased proteomics profiling a sub-study of a multi-cancer cohort enabling biomarker…

See Poster

05/01/2022

Fact Sheet

See Fact Sheet